Financial Times |
Axovant prepares to start pair of dementia drugs trials
Financial Times LBD is an umbrella term for forms of dementia that are caused by the build-up of proteins known as Lewy bodies in the brain, such as Parkinson's disease. It is the second most common form of dementia after Alzheimer's, but has attracted little … Axovant Announces Expansion of Dementia Drug Development Pipeline and Reports … |
